Casdin Capital, LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2021$5,852,000
-17.5%
75,0000.0%0.15%
-29.4%
Q1 2021$7,094,000
-22.4%
75,0000.0%0.21%
-22.1%
Q4 2020$9,139,000
+39.5%
75,0000.0%0.27%
-7.5%
Q3 2020$6,552,000
+35.3%
75,0000.0%0.29%
+2.1%
Q2 2020$4,844,000
+44.6%
75,0000.0%0.29%
-19.4%
Q1 2020$3,350,000
-28.3%
75,0000.0%0.36%
-17.2%
Q4 2019$4,672,000
-99.8%
75,0000.0%0.43%
+47.3%
Q3 2019$2,820,000,000
+15.5%
75,000
+25.0%
0.29%
+27.5%
Q2 2019$2,442,000,00060,0000.23%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders